Global Information
회사소개 | 문의 | 비교리스트

세계의 비강분무백신 시장 규모, 상황, 예측(2020-2026)에 대한 Covid-19의 영향

Covid-19 Impact on Global Nasal Spray Vaccine Market Size, Status and Forecast 2020-2026

리서치사 QYResearch
발행일 2020년 06월 상품 코드 939957
페이지 정보 영문
가격
US $ 3,900 ₩ 4,355,000 PDF (Single User License)
US $ 5,850 ₩ 6,532,000 PDF (Multi User License)
US $ 7,800 ₩ 8,710,000 PDF (Enterprise Wide License)


세계의 비강분무백신 시장 규모, 상황, 예측(2020-2026)에 대한 Covid-19의 영향 Covid-19 Impact on Global Nasal Spray Vaccine Market Size, Status and Forecast 2020-2026
발행일 : 2020년 06월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 비강분무백신(Nasal Spray Vaccine) 시장은 신종 코로나바이러스 감염증(COVID-19) 팬데믹의 영향을 받은 시나리오에서 2020년의 1억 2,100만 달러에서 2026년에는 2억 2,126만 달러로 확대될 전망이며, 2010-2026년 CAGR은 10.10%가 될 것으로 예상되고 있습니다.

세계의 비강분무백신 시장을 조사했으며, 세계의 성장 동향, 경쟁사 각사의 세력도 및 용도별 시장에 대한 COVID-19의 영향, 각 지역 시장에 대한 COVID-19의 영향, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

제1장 리포트 개요

  • 조사 범위
  • 주요 시장 부문
  • 조사 대상 기업 : 비강분무백신 매출별 순위
  • 용도별 시장
    • 용도별 세계 시장 점유율
    • 소아
    • 성인
  • Covid-19의 심각한 영향
  • 조사 목적
  • 조사 대상년

제2장 세계 시장의 성장 동향

  • 세계 시장에 대한 COVID-19의 영향
  • 각 지역 시장에 대한 COVID-19의 영향
  • 업계에 대한 COVID-19의 영향
    • 시장의 동향
    • 시장 성장요인
    • 시장이 해결해야 할 과제
    • Porter의 산업 분석

제3장 주요 기업의 세력도에 대한 COVID-19의 영향

  • 주요 기업의 세력도
  • 시장 집중도
  • 주요 기업의 본사와 설립일
  • 주요 기업의 솔루션과 서비스
  • 시장 참여 시기
  • 합병과 인수, 확장 계획

제4장 용도별 시장에 대한 COVID-19의 영향

  • 용도별 시장 규모

제5장 북미 시장에 대한 COVID-19의 영향

  • 시장 규모
  • 주요 기업
  • 용도별 시장 규모

제6장 유럽 시장에 대한 COVID-19의 영향

  • 시장 규모
  • 주요 기업
  • 용도별 시장 규모 모

제7장 일본 시장에 대한 COVID-19의 영향

제8장 중국 시장에 대한 COVID-19의 영향

  • 시장 규모
  • 주요 기업
  • 용도별 시장 규모

제9장 동남아시아 시장에 대한 COVID-19의 영향

  • 동남아시아 시장에서의 비강분무백신의 개요
  • 동남아시아 시장에서의 백신의 개요

제10장 인도 시장에 대한 COVID-19의 영향

  • 시장 규모
  • 주요 기업
  • 용도별 시장 규모

제11장 주요 기업의 개요

  • AstraZeneca FLUMIST
  • Cipla
  • BCHT

제12장 애널리스트의 시점/결론

제13장 부록

KSA 20.06.18
  • Table 1. Nasal Spray Vaccine Key Market Segments 2
  • Table 2. Ranking of Global Top Nasal Spray Vaccine Manufacturers by Revenue (US$ Million) in 2019 2
  • Table 3. Global Nasal Spray Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2020 VS 2026 3
  • Table 4. Overview of the World Economic Outlook Projections 7
  • Table 5. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) 9
  • Table 6. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) 10
  • Table 7. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) 11
  • Table 8. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) 12
  • Table 9. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) 13
  • Table 10. Covid-19 Impact: Global Major Government Policy 18
  • Table 11. Global Nasal Spray Vaccine Market Size by Regions (US$ Million): 2019 VS 2020 VS 2026 26
  • Table 12. Global Nasal Spray Vaccine Market Size by Regions (2015-2020) & (US$ Million) 28
  • Table 13. Global Nasal Spray Vaccine Market Share by Regions (2015-2020) 28
  • Table 14. Global Nasal Spray Vaccine Forecasted Market Size by Regions (2021-2026) & (US$ Million) 28
  • Table 15. Global Nasal Spray Vaccine Market Share by Regions (2021-2026) 29
  • Table 16. The Covid-19 Impact on Nasal Spray Vaccine Assessment 29
  • Table 17. COVID-19 Impact: Nasal Spray Vaccine Market Trends 31
  • Table 18. COVID-19 Impact: Drivers 31
  • Table 19. COVID-19 Impact: Nasal Spray Vaccine Challenges 32
  • Table 20. Global Nasal Spray Vaccine Revenue by Players (2015-2020) & (US$ Million) 34
  • Table 21. Global Nasal Spray Vaccine Market Share by Players (2015-2020) 34
  • Table 22. Global Top Nasal Spray Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nasal Spray Vaccine as of 2019) 35
  • Table 23. Global 5 Largest Players Market Share by Nasal Spray Vaccine Revenue (CR5 and HHI) & (2015-2020) 36
  • Table 24. Key Players Headquarters and Established Date 37
  • Table 25. Key Players Nasal Spray Vaccine Product Solution and Service 38
  • Table 26. Date of Enter into Nasal Spray Vaccine Market 38
  • Table 27. Mergers & Acquisitions, Expansion Plans 38
  • Table 28. Global Nasal Spray Vaccine Market Size by Application (2015-2020) & (US$ Million) 40
  • Table 29. Global Nasal Spray Vaccine Revenue Market Share by Application (2015-2020) 40
  • Table 30. Global Nasal Spray Vaccine Forecasted Market Size by Application (2021-2026) & (US$ Million) 41
  • Table 31. Global Nasal Spray Vaccine Revenue Market Share by Application (2021-2026) 41
  • Table 32. North America Key Players Nasal Spray Vaccine Revenue (2015-2020) & (US$ Million) 42
  • Table 33. North America Key Players Nasal Spray Vaccine Market Share (2015-2020) 42
  • Table 34. North America Nasal Spray Vaccine Market Size by Application (2015-2020) & (US$ Million) 43
  • Table 35. North America Nasal Spray Vaccine Market Share by Application (2015-2020) 43
  • Table 36. Europe Key Players Nasal Spray Vaccine Revenue (2015-2020) & (US$ Million) 44
  • Table 37. Europe Key Players Nasal Spray Vaccine Market Share (2015-2020) 44
  • Table 38. Europe Nasal Spray Vaccine Market Size by Application (2015-2020) & (US$ Million) 45
  • Table 39. Europe Nasal Spray Vaccine Market Share by Application (2015-2020) 45
  • Table 40. China Key Players Nasal Spray Vaccine Revenue (2019-2020) & (US$ Million) 47
  • Table 41. China Key Players Nasal Spray Vaccine Market Share (2019-2020) 47
  • Table 42. China Nasal Spray Vaccine Market Size by Application (2015-2020) & (US$ Million) 48
  • Table 43. China Nasal Spray Vaccine Market Share by Application (2015-2020) 48
  • Table 44. India Key Players Nasal Spray Vaccine Revenue (2015-2020) & (US$ Million) 51
  • Table 45. India Key Players Nasal Spray Vaccine Market Share (2019-2020) 51
  • Table 46. India Nasal Spray Vaccine Market Size by Application (2015-2020) & (US$ Million) 52
  • Table 47. India Nasal Spray Vaccine Market Share by Application (2015-2020) 52
  • Table 48. AstraZeneca FLUMIST Company Details 53
  • Table 49. AstraZeneca FLUMIST Revenue in Nasal Spray Vaccine Business (2015-2020) & (US$ Million) 54
  • Table 50. Cipla Company Details 55
  • Table 51. Cipla Revenue in Nasal Spray Vaccine Business (2015-2020) & (US$ Million) 56
  • Table 52. BCHT Company Details 57
  • Table 53. BCHT Revenue in Nasal Spray Vaccine Business (2015-2020) & (US$ Million) 58
  • Table 54. Research Programs/Design for This Report 60
  • Table 55. Key Data Information from Secondary Sources 64
  • Table 56. Key Data Information from Primary Sources 65
  • Figure 1. Nasal Spray Vaccine Pictures 1
  • Figure 2. Global Nasal Spray Vaccine Market Share by Application: 2020 3
  • Figure 3. Global Nasal Spray Vaccine Market Share by Application: 2026 4
  • Figure 4. Child Case Studies 4
  • Figure 5. Adult Case Studies 5
  • Figure 6. Commodity Prices-Metals Price Indices 14
  • Figure 7. Commodity Prices- Precious Metal Price Indices 15
  • Figure 8. Commodity Prices- Agricultural Raw Material Price Indices 15
  • Figure 9. Commodity Prices- Food and Beverage Price Indices 16
  • Figure 10. Commodity Prices- Fertilizer Price Indices 16
  • Figure 11. Commodity Prices- Energy Price Indices 17
  • Figure 12. G20+: Economic Policy Responses to COVID-19 18
  • Figure 13. Nasal Spray Vaccine Report Years Considered 23
  • Figure 14. Global Nasal Spray Vaccine Revenue (US$ Million), Pre-COVID-19 and Post- COVID-19 Comparison: 2015-2026 25
  • Figure 15. Global Nasal Spray Vaccine Revenue, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate: 2015-2026 25
  • Figure 16. Global Nasal Spray Vaccine Market Size (Value), (US$ Million), 2015 VS 2020 VS 2026 26
  • Figure 17. Global Nasal Spray Vaccine Market Share by Regions: 2020 27
  • Figure 18. Global Nasal Spray Vaccine Market Share by Regions: 2026 27
  • Figure 19. Global Nasal Spray Vaccine Market Share by Regions (2021-2026) 29
  • Figure 20. Porter's Five Forces Analysis 33
  • Figure 21. Global Nasal Spray Vaccine Market Share by Players in 2019 35
  • Figure 22. The Top 3 Players Market Share by Nasal Spray Vaccine Revenue in 2019 37
  • Figure 23. North America Nasal Spray Vaccine Market Size YoY Growth (2015-2026) & (US$ Million) 42
  • Figure 24. Europe Nasal Spray Vaccine Market Size YoY Growth (2015-2026) & (US$ Million) 44
  • Figure 25. China Nasal Spray Vaccine Market Size YoY Growth (2015-2026) & (US$ Million) 47
  • Figure 26. India Nasal Spray Vaccine Market Size YoY Growth (2015-2026) & (US$ Million) 51
  • Figure 27. AstraZeneca FLUMIST Nasal Spray Vaccine Product 54
  • Figure 28. Cipla Nasal Spray Vaccine Product 56
  • Figure 29. BCHT Nasal Spray Vaccine Product 58
  • Figure 30. Bottom-up and Top-down Approaches for This Report 62
  • Figure 31. Data Triangulation 63
  • Figure 32. Key Executives Interviewed 65

Market Analysis and Insights: Global Nasal Spray Vaccine Market

Prior to COVID-19, the market for Nasal Spray Vaccine was anticipated to grow from US$ 12.7.31 million in 2020 to US$ 232.97 million by 2026; it is expected to grow at a CAGR of 10.27% during 2021-2026, whereas post-COVID-19 scenario, the market for Nasal Spray Vaccine is projected to grow from US$ 121.01 million in 2020 (a change by ~5% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ 221.26 Million by 2026; it is expected to grow at a CAGR of 10.01% during 2021-2026. The solicitation of proposals by the governments and public-private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Nasal Spray Vaccine market.

Global Nasal Spray Vaccine Scope and Market Size

Nasal Spray Vaccine market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nasal Spray Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

By Company

  • AstraZeneca
  • Cipla
  • BCHT

Segment by Application

  • Child
  • Adult

By Region

  • North America
  • Europe
  • Japan
  • China
  • Southeast Asia
  • India

1 REPORT OVERVIEW 1

  • 1.1 Study Scope 1
  • 1.2 Key Market Segments 1
  • 1.3 Players Covered: Ranking by Nasal Spray Vaccine Revenue 2
  • 1.4 Market by Application 2
    • 1.4.1 Global Nasal Spray Vaccine Market Share by Application: 2019 VS 2020 VS 2026 3
    • 1.4.2 Child 4
    • 1.4.3 Adult 5
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 5
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 5
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices 13
    • 1.5.3 Covid-19 Impact: Global Major Government Policy 18
  • 1.6 Study Objectives 22
  • 1.7 Years Considered 23

2 GLOBAL GROWTH TRENDS 24

  • 2.1 COVID-19 Impact on Global Nasal Spray Vaccine Market Perspective (2015-2026) 24
  • 2.2 COVID-19 Impact on Nasal Spray Vaccine Growth Trends by Regions 26
    • 2.2.1 Nasal Spray Vaccine Market Size by Regions: 2019 VS 2020 VS 2026 26
    • 2.2.2 Nasal Spray Vaccine Historic Market Size by Regions (2015-2020) 28
    • 2.2.3 Nasal Spray Vaccine Forecasted Market Size by Regions (2021-2026) 28
  • 2.3 The Covid-19 Impact on Nasal Spray Vaccine Industry 29
    • 2.3.1 COVID-19 Impact: Nasal Spray Vaccine Market Trends 30
    • 2.3.2 COVID-19 Impact: Market Drivers 31
    • 2.3.3 COVID-19 Impact: Nasal Spray Vaccine Market Challenges 32
    • 2.3.4 Porter's Five Forces Analysis 32

3 COVID-19 IMPACT ON COMPETITION LANDSCAPE BY KEY PLAYERS 34

  • 3.1 Global Top Nasal Spray Vaccine Players by Market Size 34
    • 3.1.1 Global Top Nasal Spray Vaccine Players by Revenue (2015-2020) 34
    • 3.1.2 Global Nasal Spray Vaccine Revenue Market Share by Players (2015-2020) 34
    • 3.1.3 Global Nasal Spray Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 35
  • 3.2 Global Nasal Spray Vaccine Market Concentration Ratio 36
    • 3.2.1 Global Nasal Spray Vaccine Market Concentration Ratio (CR3 and HHI) 36
    • 3.2.2 Global Top 3 Companies by Nasal Spray Vaccine Revenue in 2019 37
  • 3.3 Nasal Spray Vaccine Key Players Headquarters and Established Date 37
  • 3.4 Key Players Nasal Spray Vaccine Product Solution and Service 37
  • 3.5 Date of Enter into Nasal Spray Vaccine Market 38
  • 3.6 Mergers & Acquisitions, Expansion Plans 38

4 COVID-19 IMPACT ON NASAL SPRAY VACCINE BREAKDOWN DATA BY APPLICATION 40

  • 4.1 Global Nasal Spray Vaccine Historic Market Size by Application (2015-2020) 40
  • 4.2 Global Nasal Spray Vaccine Forecasted Market Size by Application (2021-2026) 41

5 NORTH AMERICA IMPACT OF COVID-19 42

  • 5.1 North America Nasal Spray Vaccine Market Size (2015-2026) 42
  • 5.2 Nasal Spray Vaccine Key Players in North America (2015-2020) 42
  • 5.3 North America Nasal Spray Vaccine Market Size by Application (2015-2020) 43

6 EUROPE IMPACT OF COVID-19 44

  • 6.1 Europe Nasal Spray Vaccine Market Size (2015-2026) 44
  • 6.2 Nasal Spray Vaccine Key Players in Europe (2015-2020) 44
  • 6.3 Europe Nasal Spray Vaccine Market Size by Application (2015-2020) 45

7 JAPAN IMPACT OF COVID-19 46

8 CHINA IMPACT OF COVID-19 47

  • 8.1 China Nasal Spray Vaccine Market Size (2015-2026) 47
  • 8.2 Nasal Spray Vaccine Key Players in China (2019-2020) 47
  • 8.3 China Nasal Spray Vaccine Market Size by Application (2015-2020) 48

9 SOUTHEAST ASIA IMPACT OF COVID-19 49

  • 9.1 The Overview of Nasal Spray Vaccine in Southeast Asia 49
  • 9.2 The Overview of Vaccine in Southeast Asia 49

10 INDIA IMPACT OF COVID-19 51

  • 10.1 India Nasal Spray Vaccine Market Size (2015-2026) 51
  • 10.2 Nasal Spray Vaccine Key Players in India (2015-2020) 51
  • 10.3 India Nasal Spray Vaccine Market Size by Application (2015-2020) 52

11 KEY PLAYERS PROFILES 53

  • 11.1 AstraZeneca FLUMIST 53
    • 11.1.1 AstraZeneca FLUMIST Company Details 53
    • 11.1.2 AstraZeneca FLUMIST Nasal Spray Vaccine Introduction 54
    • 11.1.3 AstraZeneca FLUMIST Revenue in Nasal Spray Vaccine Business (2015-2020) 54
  • 11.2 Cipla 55
    • 11.2.1 Cipla Company Details 55
    • 11.2.2 Cipla Nasal Spray Vaccine Introduction 56
    • 11.2.3 Cipla Revenue in Nasal Spray Vaccine Business (2015-2020) 56
  • 11.3 BCHT 57
    • 11.3.1 BCHT Company Details 57
    • 11.3.2 BCHT Nasal Spray Vaccine Introduction 58
    • 11.3.3 BCHT Revenue in Nasal Spray Vaccine Business (2015-2020) 58

12 ANALYST'S VIEWPOINTS/CONCLUSIONS 59

13 APPENDIX 60

  • 13.1 Research Methodology 60
    • 13.1.1 Methodology/Research Approach 60
    • 13.1.2 Data Source 63
  • 13.2 Disclaimer 66
  • 13.3 Author Details 67
Back to Top
전화 문의
F A Q